Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT.

NCT00680550 is registered in ClinicalTrials.gov with Medtronic BRC as lead sponsor.

NCT NCT00680550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00680550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT.
Lead sponsor
Medtronic BRC
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
April 30, 2013
Enrollment
1,003 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiac arrhythmias